BMY vs UPLD · P/E 17, rev $24.46B vs rev $97.8M
Bristol-Myers Squibb Company (BMY) versus Upland Software Inc (UPLD) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Upland Software Inc (UPLD) is a software - application company listed on NASDAQ.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported UPLD revenue for 2026-06-30 was $97.8M. Net income was -$36.5M. UPLD currently screens at market cap $15.2M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. UPLD currently screens at market cap $15.2M.
Not investment advice. Open the BMY and UPLD stock pages for the full models.
Not investment advice.